Search Results 1601-1610 of 16154 for chemoprevention

1. Science Saturday: Finding the right drug, dose for cancer therapy through pharmacogenomics - Mayo Clinic News Network

   Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...

2. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

   The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based ...

3. Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology - Mayo Clinic

   This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer ...

4. Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers

   PHOENIX — A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect ...

5. Mayo Clinic Q & A – Breast Cancer Survivorship – Dr. Daniela...

   Dr. Daniela Stan 00:05. I feel that the diagnosis is always very hard. The hardest period of time is actually from the diagnosis until we start to make a ...

6. Housecall: Don't let jet lag drag you down

   Symptoms include daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. A few basic steps may prevent jet lag or reduce its ...

7. A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene - Mayo Clinic

   The purpose of this study is to determine the safe dose of EPZ-5676, to evaluate the safety of EPZ-5676 in patients with advanced hematologic malignancies, and ...

8. GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC - Mayo Clinic

   About this study. The purpose of this study is to evaluate whether CAN-2409 + prodrug added to standard of care immune checkpoint inhibitor (ICI) therapy ...

9. WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome - Mayo Clinic

   WEE1 inhibitor AZD1775 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

10. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) - Mayo Clinic

    Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Tumors with this mutation may respond to treatments ...